Tagged with IT

Array   An in-depth viewpoint on the current taxation situation for pharmaceutical companies operating in Belgium today, looking at incentive programs and relative positioning in Europe. Mr Eynatten, can you please provide our readers with an overview of the value added services that Deloitte offers to the life sciences industry in…

Health Sciences Authority HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore. However, we are quite unique because we also run the national blood service and we have an Applied Sciences Group that looks into laboratory…

Australia Would you begin by giving an introduction to our international readers of the institute, highlighting recent milestones & achievements and the current focus areas of its research activities? Broadly speaking, The George Institute for Global Health is an academic research organization that focuses on high impact clinical research. We do…

The George Institute For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in cardiovascular physiology I moved to Boston to work at MIT on neurotransmitters in the brain and the effects on blood pressure. From Boston I moved to Hammersmith hospital in London…

Grupo Vitalmex Mexico Can you give us a historical overview of the company and tell us about the vision behind its creation? Vitalmex is a very humanistic company that puts the patient at the center. We focus on a very specific strategy based on 3 goals: Accessibility, availability, and opportunity. There is clearly…

IMSS (Mexican Institute of Social Security) IMSS is a central pillar in the Mexican healthcare system, covering all Mexicans working for the declared formal private sector. How do you assess the quality of the healthcare that is provided by IMSS? To assess the efficiency of our services, it is key to look at the amount of…

GlaxoSmithKline Mexico You worked several years ago in Mexico, and there have been significant changes in the country since then. From your perspective, how did the Mexican pharmaceutical landscape shift over the past few years, and how did that impact GSK’s strategy in the country? Indeed, there have been some important changes…

EDBI/Bio One Capital As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the strategic corporate investment arm of the Singapore Economic Development Board (EDB) and we invest in very select industry sectors. Investments in the Biomedical Sciences…

Austroplant Arzneimittel Can you give our readers a snapshot of Austroplant’s scope of activities and its structure in Austria and the central European market? Austroplant/Dr Peithner belongs to the Schwabe Group, the worldwide leader in herbal medicine products. It was sold to the Schwabe Group as a family business in 2009. Dr.…

Singapore Management University (SMU) Since the last time we had the pleasure of meeting you, 4 years ago, what have been the main developments and changes in the Singaporean pharmaceutical industry? One of the most important changes was that Singapore and India signed a MoU; within this treaty Indian generic drugs will benefit from…

GlaxoSmithKline (GSK) The company’s current corporate strategy includes a major focus on the Emerging Markets and Asia Pacific (EMAP) region. Concretely, what are the expectations and the main objectives for the Asia Pacific region? GSK Asia Pacific is composed of: North East Asia, South East Asia and South Pacific (this includes countries…

ireland Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in pharmacology. I have worked for Servier for my entire career. I started in the industry as a medical representative for the company. I went…